Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 7:05 AM ET

Healthcare Providers and Services

Company Overview of Miraca Life Sciences, Inc.

Company Overview

Miraca Life Sciences, Inc. operates clinical pathology laboratories that provide diagnostic services in the fields of dermatology, gastroenterology, hematology, and urology in the United States. It focuses on the development of a blood-based diagnostics platform to address unmet clinical needs in the gastrointestinal cancer spectrum that range from screening and diagnosis to prognosis and therapeutic guidance. The company also provides urologic pathology services, including microscopy and immunohistochemistry with integrated molecular diagnostic services; and UroVysion, a deoxyribonucleic acid-based urine test that detects genetic changes in bladder cells. In addition, it offers general surg...

6655 North MacArthur Boulevard

Irving, TX 75039

United States

Founded in 1996

Phone:

214-277-8700

Fax:

972-331-3148

Key Executives for Miraca Life Sciences, Inc.

Chief Executive Officer and President
Vice Chairman
Vice Chairman
Age: 67
Chief Financial Officer
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2015.

Miraca Life Sciences, Inc. Key Developments

Miraca Life Sciences, Inc Formalizes and Expands Breast Pathology Business; Names Raheela Ashfaq as Director of Breast Pathology

Miraca Life Sciences has formalized and expanded its breast pathology offering, to include critical testing for both cancer risk and prognosis. Expansion includes new services for clinicians, including interventional radiologists, breast surgeons, and breast oncologists: Breast icon_cmyk. Miraca Life Sciences’ breast pathology services feature: Definitive diagnoses of breast conditions, consensus-based approach to terminology and diagnostic criteria, quantitative prognostic markers, heredity breast cancer panels, molecular tumor profiling, TNM (tumor, lymph nodes, metastasis) staging, and daily consensus conferences to review difficult cases and ensure the most definitive diagnoses. The expansion of the breast pathology offering is made possible in part by the capabilities provided by Baylor Miraca Genetics Laboratories, a joint venture of Miraca Holdings and the Baylor College of Medicine that was finalized last month. Raheela Ashfaq, MD, has been named Director of Breast Pathology. She also serves on the scientific advisory board of Baylor Miraca Genetics Laboratories. Dr. Ashfaq has more than 20 years of experience in diagnosing breast conditions, both at Miraca Life Sciences and at University of Texas Southwestern Medical Center at Dallas. Previously as the Medical Director of Caris Life Sciences, she helped to launch molecular profiling for breast cancer.

Modernizing Medicine and Miraca Life Sciences to Launch EMA Urology

Modernizing Medicine and Miraca Life Sciences announced plans to launch EMA Urology, an electronic medical records system designed for urologists. With specialty-specific systems for dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology and plastic and cosmetic surgery, Modernizing Medicine will expand its product portfolio with a solution for the underserved urology market that lacks a template-free, cloud solution with EMA's features. Like the company's other EMA systems, EMA Urology will be available as a native iPad application with the same convenient touch-screen functionality that frees providers from tedious typing. Combined with a seamless integration with Miraca Life Sciences, providers will enjoy having additional time saved to focus on patient care. Also available from any web-enabled Mac or PC, EMA Urology will have the EMA adaptive learning engine that adjusts to a doctor's unique style of practice and remembers preferences. Free of templates, Modernizing Medicine's electronic health records system eliminates cloning and documents each individual patient exam uniquely. EMA also integrates with hundreds of practice management solutions.

Modernizing Medicine, Inc. and Miraca Life Sciences, Inc. Partner to Create Enhanced EMR and Pathology Lab Integration

Modernizing Medicine, Inc. and Miraca Life Sciences, Inc. announced that they are partnering to develop an enhanced diagnostic data bridge. Pathologists normally analyze tissue samples with limited clinical background on patients, which can delay accurate diagnoses. EMA dermatologists and MLS pathologists will be able to share additional diagnostic information, which can help the pathologist create a more timely, informed and accurate analysis. Modernizing Medicine's user-friendly EMA adapts to each healthcare provider's unique style of practice and integrates seamlessly into the practice's workflow, saving physicians and their staff time and increasing efficiencies. EMA's cloud-based approach to collecting and storing patient information enables physicians to utilize the EMA Network(TM) to create, visualize and consume treatment data to better care for their patients.

Similar Private Companies By Industry

Company Name Region
HCA - HealthONE LLC United States
Senior Living Communities, LLC United States
Wishard Health Services, Inc. United States
Cape Fear Valley Health System Specialty Group, LLC United States
Excel Healthcare, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Miraca Life Sciences, Inc., please visit www.miracalifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.